Geneva, Switzerland (Running Africa) — UNAIDS Executive Director Winnie Byanyima has warned that plans by the United States to reduce HIV/AIDS funding for South Africa could jeopardize decades of progress in the fight against the epidemic and place millions of vulnerable people at risk.
Speaking amid growing concerns over global health funding, Byanyima urged Washington to reconsider its decision or ensure a carefully managed transition to avoid disruptions to life-saving treatment and prevention program.
The United States recently confirmed plans to gradually scale back support through the President’s Emergency Plan for AIDS Relief (PEPFAR), arguing that South Africa, as a middle-income country, should increasingly finance its own HIV response. US officials have also cited concerns that South Africa has not met certain policy expectations linked to continued funding.
For more than two decades, PEPFAR has played a central role in South Africa’s HIV response, contributing more than $400 million annually and supporting approximately 15,000 healthcare workers. The program accounts for an estimated 17 percent of the country’s HIV/AIDS funding.
South Africa is home to the world’s largest population of people living with HIV, making any reduction in international support a significant concern for public health experts.
Byanyima warned that abrupt funding cuts could disrupt treatment program, reduce access to HIV testing, and weaken prevention efforts that have helped drive down infection rates over recent years. She emphasized that maintaining continuity of care is critical to preventing setbacks in the global fight against HIV/AIDS.
The concerns extend beyond South Africa. UNAIDS says declining international development assistance is already affecting HIV program worldwide, with some countries reporting reductions in testing services, community outreach efforts, and prevention initiatives such as condom distribution.
Despite major advances in treatment access, global challenges remain. More than 32 million people are currently receiving antiretroviral therapy, but an estimated nine million people living with HIV still lack access to treatment. Approximately 1.2 million new HIV infections were recorded worldwide last year.
Health experts warn that reductions in funding could reverse years of progress, increase transmission rates, and place additional pressure on healthcare systems already facing financial constraints.
As governments and international donors reassess development priorities, public health advocates continue to call for sustained investment to ensure gains made against HIV/AIDS are not lost and that vulnerable populations remain protected.
